feed,title,long_url,short_url
SeekingAlpha,SAB Biotherapeutics says mid-stage trial for influenza therapy met main goal,https://seekingalpha.com/news/3775730,
SeekingAlpha,Ambarella price target boosted to $230 at KeyBanc on earnings beat,https://seekingalpha.com/news/3775727,
SeekingAlpha,Daktronics reports FQ2 results,https://seekingalpha.com/news/3775729,
SeekingAlpha,Amazon announces further expansion into low-carbon energy,https://seekingalpha.com/news/3775728,
